M. O'Donovan

发表

MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls

Simon C. Potter, M. Pirinen, P. Donnelly, 2017, Translational Psychiatry.

Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: results from the EUGEI study

P. Delespaul, J. Bobes, P. Sáiz, 2021 .

Levels of GABAa receptor subunit mRNA in rat brain following flurazepam treatment

P. McGuffin, P. Buckland, M. O’Donovan, 1992, Journal of psychopharmacology.

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

M Mancuso, R Ferri, P. Bosco, 2012, Molecular Psychiatry.

Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study.

M. Owen, P. McGuffin, J. Barrett, 2001, American journal of medical genetics.

Tryptophan pyrrolase gene expression in an alcohol preferring and non‐preferring mouse strain

P. McGuffin, P. Buckland, M. O'Donovan, 1998, Addiction biology.

Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter

P. McGuffin, P. Buckland, G. Spurlock, 1994, Neuropharmacology.

Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

P. Delespaul, J. Bobes, P. Sáiz, 2021, European Psychiatry.

New insights on the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

M. Rietschel, K. Tansey, G. Breen, 2017, bioRxiv.

Short acting benzodiazepines.

P. McGuffin, M. O'Donovan, 1993, BMJ.